Ofatumumab, a novel anti-CD20 monoclonal antibody for the treatment of B-cell malignancies.
Cheson BD; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2010, vol. 28, issue 21, p 3525, ISSN 15277755. ISBN 15277755.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef